Natalizumab Biosimilar – Anti-ITGA4, CD49d mAb – Research Grade

Reference:
Size

,

Isotype

IgG4, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameNatalizumab Biosimilar - Anti-ITGA4, CD49d mAb - Research Grade
SourceCAS 189261-10-7
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsNatalizumab,AN 100226,BG00002,ITGA4, CD49d,anti-ITGA4, CD49d
ReferencePX-TA1053
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Natalizumab Biosimilar - Anti-ITGA4, CD49d mAb - Research Grade

General information on Anti-ITGA4/CD49d(Homo sapiens) (Natalizumab) Monoclonal Antibody

Natalizumab is a humanized monoclonal antibody produced in murine myeloma cells of isotype IgG4k. Natalizumab contains a human framework region and a complementarity determining region of a murine antibody that binds to alpha 4-integrin. Natalizumab has been temporarily discontinued due to the risk of progressive multifocal leukoencephalopathy (PML).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Natalizumab Biosimilar – Anti-ITGA4, CD49d mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

ITGA4 recombinant protein
Antigen

ITGA4 recombinant protein

PX-P5178 500$
Human IgG4 Isotype Control antibody
Isotype Control

Human IgG4 Isotype Control antibody

PTX17887 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products